TLR8 antagonist-2 (Compound 35) is a selective TLR8 antagonist with an IC50 of 0.032 µM against hTLR8. TLR8 antagonist-2 potently inhibits TLR8-dependent NF-kappaB activity in cells stimulated with TL8-506 (HY-20457). TLR8 antagonist-2 can be used in research related to inflammatory and immune diseases[1].
Molekulargewicht:
418.53
Formel:
C25H30N4O2
Target-Kategorie:
NF-kappaB,Toll-like Receptor (TLR)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten